We are live on ! Find out more
DBG

De Burlo Group Portfolio holdings

AUM $441M
1-Year Est. Return 21.21%
This Fund
S&P 500
This Quarter Est. Return
+5.94%
1 Year Est. Return
+21.21%
3 Year Est. Return
+98.05%
5 Year Est. Return
+220.33%
10 Year Est. Return
+1,846.98%
AUM
$830M
AUM Growth
+$70.8M
Cap. Flow
+$31.3M
Cap. Flow %
3.77%
Top 10 Hldgs %
42.39%
Holding
84
New
4
Increased
26
Reduced
27
Closed
6

Top Buys

Rank Stock Value
1
NVO
Novo Nordisk
NVO
+$28.2M
2
AMD icon
Advanced Micro Devices
AMD
+$25.5M
3
MCK icon
McKesson
MCK
+$21.9M
4
TER icon
Teradyne
TER
+$19M
5
INTU icon
Intuit
INTU
+$16.9M

Sector Composition

Rank Sector Weight
1 Technology 32.99%
2 Consumer Discretionary 16.28%
3 Healthcare 14.61%
4 Financials 12.87%
5 Communication Services 8.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CWST icon
76
Casella Waste Systems
CWST
$5.69B
$209K 0.03%
+2,200
New +$221K
IART icon
77
Integra LifeSciences
IART
$1.54B
$207K 0.03%
14,463
FISV
78
Fiserv Inc
FISV
$27.2B
$202K 0.02%
1,563
AMP icon
79
Ameriprise Financial
AMP
$46.8B
-8,590
Closed -$4.58M
GWW icon
80
W.W. Grainger
GWW
$65.3B
-9,500
Closed -$9.88M
IR icon
81
Ingersoll Rand
IR
$33B
-81,200
Closed -$6.75M
ISRG icon
82
Intuitive Surgical
ISRG
$121B
-35,900
Closed -$19.5M
ITW icon
83
Illinois Tool Works
ITW
$81.4B
-1,164
Closed -$288K
NOW icon
84
ServiceNow
NOW
$102B
-21,750
Closed -$4.47M

Similar funds

De Burlo Group's Q3 2025 Portfolio in Review

As of Q3 2025, De Burlo Group held 84 positions worth $830M, up 9.3% from $759M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

De Burlo Group deployed $31.3M of net new capital in Q3 2025, opening 4 new positions and adding to 26 existing holdings. Its largest new stake was Novo Nordisk: 481,160 shares worth $26.7M.

By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 31% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Vertex Pharmaceuticals, an estimated $18.3M trimmed.

  • De Burlo Group's largest Q3 2025 buy was Novo Nordisk: 481,160 shares worth $26.7M.
  • De Burlo Group added most to Advanced Micro Devices in Q3 2025, an estimated $25.5M increase.
  • De Burlo Group's biggest Q3 2025 reduction was Vertex Pharmaceuticals, cutting an estimated $18.3M.
  • De Burlo Group fully exited Intuitive Surgical in Q3 2025, selling an estimated $19.5M.
  • De Burlo Group's ten largest holdings make up 42% of its $830M portfolio in Q3 2025.
  • De Burlo Group opened 4 new positions and closed 6 in Q3 2025.
  • De Burlo Group's portfolio value rose 9.3% quarter-over-quarter to $830M.

Based on De Burlo Group's 13F filing for Q3 2025, filed 13 Nov 2025.